Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitors

Seymore L, 1999, Cancer Treat Rev, 25, 301, 10.1053/ctrv.1999.0134

10.1126/science.3798106

Sharma PS, 2009, Curr Pharm Des, 15, 758, 10.2174/138161209787582219

DiCicco-Bloom E, 2000, Dev Biol, 219, 197, 10.1006/dbio.2000.9604

10.1126/science.2470152

Scheurle D, 2000, Anticancer Res, 20, 2091

Cox G, 2001, Int J Cancer, 92, 480, 10.1002/ijc.1214

Gullick WJ, 1991, Br Med Bull, 47, 87, 10.1093/oxfordjournals.bmb.a072464

Moscatello DK, 1995, Cancer Res, 55, 5536

Wikstrand CJ, 1997, Cancer Res, 57, 4130

Bridges AJ, 1999, Curr Med Chem, 6, 825, 10.2174/092986730609220401151141

Boschelli DH, 1999, Drugs Future, 24, 515, 10.1358/dof.1999.024.05.858622

10.1016/0092-8674(90)90801-K

10.1146/annurev.biochem.69.1.373

10.1021/jm050458h

10.1021/jm061280h

Lv PC, 2010, Bioorg Med Chem, 18, 314, 10.1016/j.bmc.2009.10.051

Lv PC, 2010, Bioorg Med Chem, 18, 1117, 10.1016/j.bmc.2009.12.048

Engler TA, 1996, Bioorg Med Chem, 4, 1755, 10.1016/0968-0896(96)00192-7

Dai JR, 1998, J Nat Prod, 61, 351, 10.1021/np970519h

Diyasena MNC, 1985, J Chem Soc Perkin Trans, 1, 1807, 10.1039/p19850001807

Dean FM. (1973). In: ApSimon J, ed. The total synthesis of natural products. Vol. 1. New York: Wiley, 513.

Carminati, 1965, Chem Abstr, 63, 12167

Bestetal, 1951, Chem Abstr, 45, 9737

Al-Khalil S. The 1st Palestinian Medical and Health conference. August, 2005.

Sakamoto M, 1995, Chem Abstr, 123, 143655m

Fahmy IR, 1947, Quart J Pharm Pharmacol, 20, 281, 546

Scott VM, 1976, Mutat Res, 39, 29, 10.1016/0165-1110(76)90012-9

Musajo L, 1954, Bull Soc Chim Biol, 36, 1213

Vermel EM, 1964, Vopr Onkol, 10, 85

Fujioka T, 1999, Chem Pharm Bull, 47, 96, 10.1248/cpb.47.96

Gammill RB, 1983, J Med Chem, 26, 1672, 10.1021/jm00366a002

Mashkovskii MD, 1993, Vilnius, 1, 396

10.1016/0378-8741(85)90088-1

Filler R, 1993, Organofluorine compounds in medicinal chemistry and biomedical applications.

Nitiss JL, 1998, Biochim Biophys Acta, 1400, 63, 10.1016/S0167-4781(98)00128-6

10.1038/nrm831

Lehninger AL, Nelson DL, Cox MM. (1993). In principles of biochemistry. Chapter 5. New Delhi: CBS Publishers and Distributors, 113.

10.1021/jm020964w

D’Arpa P, 1989, Biochim Biophys Acta, 989, 163

Lansiaux A, 2001, Chem Res Toxicol, 14, 16, 10.1021/tx000145j

Sundberg RJ. (1996). In: Katritzky AR, Rees CW, eds. Comprehensive heterocyclic chemistry II. Vol. 4. Oxford: Pergamon, 370–376.

Fritz JE, 2001, Bioorg Med Chem Lett, 11, 1643, 10.1016/S0960-894X(01)00250-5

Meagher KL, 2001, Bioorg Med Chem Lett, 11, 1885, 10.1016/S0960-894X(01)00334-1

Sosnovs K, 2000, Mendeleev Commun, 10, 238, 10.1070/MC2000v010n06ABEH001312

Jeffreu JL, 2007, J Med Chem, 50, 409, 10.1021/jm0608107

Masafumi K, 2010, J Nat Med

10.1016/S0960-894X(01)00344-4

Schwesinger R, 1987, Angew Chem (International English Edition), 26, 1167, 10.1002/anie.198711671

Moyer JD, 1997, Cancer Res, 57, 4838

Acheson RM, 1985, J Chem Soc Perkin Trans, 2, 1913, 10.1039/p29850001913

Walter W, 1975, Liebigs Ann Chem, 275, 10.1002/jlac.197519750212

Nagarajan K, 1985, Helv Chim Acta, 68, 900, 10.1002/hlca.19850680411

Shinde BR, 1990, Indian J Chem, 29, 711

Chen R, 1992, Gaodeng Xuexiao Huaxue Xuebao, 923, 102089

Nilov DB, 1998, Khim Farm Zh, 7, 16

Nilov DB, 1992, Khim Farm Zh, 63, 9

Dozorova EN, 1991, Khim Geterotsikl Soedin, 754

10.1074/jbc.M207135200

Raymond E, 2000, Drugs, 60, 15, 10.2165/00003495-200060001-00002

Ismail NS, 2011, Bioorg Med Chem, 19, 374, 10.1016/j.bmc.2010.11.017

10.1016/j.bmc.2006.02.031

Alley MC, 1988, Cancer Res, 48, 589

Grever MR, 1992, Semin Oncol, 19, 622

10.1002/ddr.430340203

10.1038/nrc1189

Elgazwy ASSH, 2010, Bioorg Med Chem, 18, 7639, 10.1016/j.bmc.2010.08.033